Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum].

Read the original articleNiu S, Ren Q, Chen S, et al. Diabetes Metab Syndr Obes. 2023;16:2549–2560.The authors have advised the correspondence section on page 2549 is incorrect. The correct correspondence details are as follows.Correspondence: Shuchun Chen, Department of Endocrinology, Hebei General Hospital, Shijiazhuang, Hebei, People's Republic of China, Email [email protected]The authors apologize for this error.By Shu Niu; Qingjuan Ren; Shuchun Chen; Xiaoyu Pan; Lin Yue; Xing Chen; Zelin Li and Ruoxi ZhenReported by Author; Author; Author; Author; Author; Author; Author; Author [Extracted from the article]